Company intelligence

ICUI

ICU Medical, Inc. · NASDAQ · Healthcare

Price$182.24-0.17% · −$0.31

Market cap4.55BEquity value

P / E22.8Trailing ratio

Volume130.35KLatest session

Market data

ICUI price chart

TradingView

Related signals

1 min delayed

Browse public ICUI signals with their source context and measured market impact. Open any signal for its permanent analysis page.

ICUIAug 7, 2026+10.93% since signal

ICU Medical posts upbeat Q2; near-term upside depends on guidance

ICU Medical reported upbeat second-quarter earnings, signaling resilience, but the piece provides no revenue or EPS figures or guidance. The key catalyst will be management commentary on margins and the updated full-year outlook. If guidance is constructive, the stock could rally in the near term; if not, gains may be limited.

View signal analysis

ICUIMay 7, 2024

ICU Medical (ICUI) Q1 Earnings and Revenues Surpass Estimates

- ICU Medical reported earnings of $0.96 per share, beating the Zacks Consensus Estimate. - The company surpassed revenue estimates for the quarter ended March 2024. - ICU Medical's stock has added about 1% YTD, underperforming the S&P 500. - The company's earnings outlook is currently a Zacks Rank #3 (Hold). - BioLife Solutions, Inc. is expected to report a quarterly loss of $0.26 per share. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings

View signal analysis

Research